[Cytokine spectrum in patients with chronic hepatitis C in the treatment with interferon-alpha drugs].
To evaluate the trend in content of IL-1, 2, 4, 6, TNF-alpha, interferon-alpha (Inf-alpha) and gamma (Inf-g) in the serum of patients with chronic hepatitis C (CHC) in the course of treatment with Inf-alpha. The study included 30 patients with CHC (20 males and 10 females) and 25 healthy controls. Markers of CHC were detected with enzyme immunoassay, RNA--with polymerase chain reaction. Index of histological activity was calculated for 20 patients. Immune response mediators were determined with enzyme immunoassay before therapy with intron A in a dose 3000000 U 3 times a week and after 12 weeks of such treatment. Before the treatment absolute levels of inflammation mediators were high, after 3 months of treatment RNA of VHC was absent in 16 (55%) of the patients, 18 (60%) had low activity of transaminases. In 6 months VHC-RNA was not detected in 8 (28%) patients. Patients with a persistent positive effect had Ifn-g significantly higher than in unstable effect. IL-4 showed an opposite trend. High concentrations of IL-4 and low of Ifn-g in the serum of CHC patients before If treatment determined high activity of Th-2 system mediators, active replication of HCV and worse response to therapy.